Chemotherapy exposure has included Zoladex, Navelbine with Avastin, Gemzar with Avastin, and then Doxil during the past two years, and most recently Xeloda.
-Hypertension- diagnosed in [**7-26**] treated with atenolol and HCTZ.
-GERD -History of endometrial hyperplasia status post biopsy in [**2098**] for postmenopausal bleeding -Status post cholecystectomy .
She underwent mastectomy, chemotherapy and was disease free for approximately 8-10 years.
CT of chest and abdomen show pleural thickening on the left, stable left pleural effusion, bilateral lung nodules, as well as several liver lesions and involvement of many vertebral bones and the right SI joint with metastatic foci.
She had a bone scan on [**2104-6-9**] that showed uptake in her sternum, bilateral ribs, C-spine and iliac bone.
Father died in his 70s of complications of end-stage liver disease from hepatitis C.  She had one brother who died at age 24 of complications of kidney transplant.
MR HEAD W/O CONTRAST; MRA BRAIN W/O CONTRAST	Study Date of [**2107-12-5**]: IMPRESSION: Limited study due to lack of intravenous contrast, which was not administered due to patient's renal failure.
The sharp waves (more in the right central region than in the left temporal) indicate areas of cortical hypersynchrony and were occasionally rhythmic for a few seconds, but they did not include simple spike or sharp and slow wave complexes or definite electrographic seizures.
SELECTED HEMATOLOGIES: [**2107-12-2**] 09:40AM BLOOD WBC-18.4*# RBC-3.43* Hgb-9.6* Hct-31.2* MCV-91 MCH-28.1 MCHC-30.9* RDW-24.2* Plt Ct-313 [**2107-12-6**] 04:10AM BLOOD WBC-4.9 RBC-2.82* Hgb-7.9* Hct-24.6* MCV-87 MCH-28.1 MCHC-32.2 RDW-24.7* Plt Ct-102* [**2107-12-7**] 05:26AM BLOOD WBC-0.9*# RBC-2.86* Hgb-8.0* Hct-24.3* MCV-85 MCH-28.2 MCHC-33.1 RDW-24.7* Plt Ct-64* [**2107-12-8**] 12:00AM BLOOD WBC-0.3*# RBC-2.99* Hgb-8.6* Hct-25.5* MCV-86 MCH-28.8 MCHC-33.6 RDW-24.3* Plt Ct-69* [**2107-12-9**] 12:00AM BLOOD WBC-0.1*# RBC-3.04* Hgb-8.7* Hct-26.5* MCV-87 MCH-28.5 MCHC-32.7 RDW-24.1* Plt Ct-58* [**2107-12-11**] 12:45AM BLOOD WBC-1.7*# RBC-2.99* Hgb-8.8* Hct-26.1* MCV-87 MCH-29.3 MCHC-33.5 RDW-24.2* Plt Ct-97*#  SELECTED COAGULOPATHIES: [**2107-12-3**] 01:18PM BLOOD PT-18.2* PTT-49.6* INR(PT)-1.7* [**2107-12-9**] 12:00AM BLOOD PT-15.8* PTT-25.2 INR(PT)-1.4*  SELECTED CHEMISTRIES: [**2107-12-3**] 01:18PM BLOOD Glucose-94 UreaN-145* Creat-7.2*# Na-140 K-4.1 Cl-107 HCO3-8* AnGap-29* [**2107-12-2**] 09:40AM BLOOD ALT-27 AST-56* LD(LDH)-361* AlkPhos-436* TotBili-0.7 [**2107-12-7**] 05:26AM BLOOD Glucose-149* UreaN-126* Creat-4.9* Na-140 K-4.5 Cl-106 HCO3-18* AnGap-21* [**2107-12-7**] 05:26AM BLOOD ALT-31 AST-96* AlkPhos-331* TotBili-3.0* DirBili-2.3* IndBili-0.7 [**2107-12-11**] 12:45AM BLOOD Glucose-190* UreaN-140* Creat-4.3* Na-142 K-4.9 Cl-107 HCO3-17* AnGap-23* [**2107-12-11**] 12:45AM BLOOD ALT-30 AST-39 LD(LDH)-429* AlkPhos-275* TotBili-2.6* [**2107-12-11**] 12:45AM BLOOD Albumin-2.2* Calcium-6.7* Phos-5.6* Mg-2.2  MISCELLANEOUS LAB RESULTS: [**2107-12-7**] 05:26AM BLOOD Ammonia-77* [**2107-12-7**] 02:18PM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE HBcAb-NEGATIVE [**2107-12-2**] 09:40AM BLOOD CEA-86* CA27.29-568* [**2107-12-7**] 02:18PM BLOOD HEPATITIS C - RIBA-NEGATIVE  MICROBIOLOGY: [**2107-12-10**]	STOOL	CLOSTRIDIUM DIFFICILE TOXIN A & B TEST-FINAL	(NEGATIVE) [**2107-12-7**]	BLOOD CULTURE	Blood Culture, Routine-FINAL {[**Female First Name (un) **] ALBICANS}; Aerobic Bottle Gram Stain-FINAL [**2107-12-7**]	BLOOD CULTURE	Blood Culture, Routine-FINAL	(NO GROWTH) [**2107-12-6**]	BLOOD CULTURE	Blood Culture, Routine-FINAL	(NO GROWTH) [**2107-12-6**]	MRSA SCREEN	MRSA SCREEN-FINAL	(NEGATIVE) [**2107-12-5**]	BLOOD CULTURE	Blood Culture, Routine-FINAL	(NO GROWTH) [**2107-12-5**]	BLOOD CULTURE	Blood Culture, Routine-FINAL	(NO GROWTH) [**2107-12-5**]	STOOL	CLOSTRIDIUM DIFFICILE TOXIN A & B TEST-FINAL	(NEGATIVE) [**2107-12-4**]	BLOOD CULTURE	Blood Culture, Routine-FINAL	(NO GROWTH) [**2107-12-4**]	BLOOD CULTURE	Blood Culture, Routine-FINAL	(NO GROWTH) [**2107-12-3**]	URINE	URINE CULTURE-FINAL	(NO GROWTH) [**2107-12-3**]	BLOOD CULTURE	Blood Culture, Routine-FINAL {BETA STREPTOCOCCUS GROUP B}; Anaerobic Bottle Gram Stain-FINAL; Aerobic Bottle Gram Stain-FINAL  Brief Hospital Course: MICU COURSE:  ## Acute renal failure: Pt presented with creatinine of 6.9. anion gap of 26 and lactate of 4.6.
Intrinsic etiologies were of concern, including NSAID induced nephropathy.
The renal service was consutled and recommended bicarb administration PRN, Calcium repletion, Phosphate bidners.
The patient was treated with Vancomycin for ?port-a-cath infection; given penicillin allergy, Vancomycin was chosen as the antibiotic of choice.
If become positive, will need tohave line removed...  # Leukocytosis: WBC increased after receiving decadron with the taxol and is likely steroid and infection induced.
Marrow supression is consistent side effect of Taxol, however, and patinet rec'd Taxol less than two weeks ago.
ANC was pending at time of d/c to floor...  # Hypertension: Patient with systol pressures generaly in the 130's throughout ICU course.
Home medications were not administered in the ICU.
Cycle 1, Day 1 of Taxol was [**12-2**].
2) Acute renal failure: Family made decision to pursue hospice, they desired no additional HD treatments.
[**2107-12-9**] renal team was notified and dialysis catheter was removed.
3) Weakness/Confusion: Originally thought to be secondary to renal failure, but did not improve with hydration and HD.
The patient began XRT on [**12-6**] with plan for competion of 10 doses, though she was made CMO and did not receive additional WBRT after [**2107-12-9**].
The patient was treated with Vancomycin for ?port-a-cath infection, given penicillin allergy.
She received Fluconazole 200 mg IV Q24H while in hospital per family request but did not receive any fluconazole at discharge.
She received symptomatic relief with viscous lidocaine via swab to mouth.
She was on neutropenic precautions & diet.
She was managed with olanzapine oral dissolving tab 2.5 PRN anxiety.
Medications on Admission: Atenolol 50mg PO daily Dexamethasone 8mg PO the night before and the morning of Taxol HCTZ 12.5mg PO daily Ranitidine 150mg PO daily Tussionex 5mL PO TID prn Vitamin B12 Pyridoxine Lac-Hydrin 12% lotion [**Hospital1 **] Loperamide prn  Discharge Medications: 1.
Oxycodone 20 mg/mL (1 mL) Concentrate Sig: 5-10 mg PO q2 hours as needed for pain: Sublingual.
Levsin 0.125 mg Tablet Sig: 1-2 Tablets PO every four (4) hours as needed.
Olanzapine 5 mg Tablet, Rapid Dissolve Sig: 0.5-1 Tablet, Rapid Dissolve PO TID (3 times a day) as needed for anxiety.
Discharge Disposition: Home With Service  Facility: [**Last Name (un) 2646**]  Discharge Diagnosis: Acute renal failure Altered mental status Hepatic encephalopathy Multiple brain metastases Metastatic breast cancer Candidemia Group B strep bacteremia Neutropenia   Discharge Condition: Comfort measures only.
